HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pak H Chan Selected Research

Brain Ischemia (Cerebral Ischemia)

1/2015Postconditioning mitigates cell death following oxygen and glucose deprivation in PC12 cells and forebrain reperfusion injury in rats.
2/2013Complement component 3 inhibition by an antioxidant is neuroprotective after cerebral ischemia and reperfusion in mice.
1/2013Prevention of JNK phosphorylation as a mechanism for rosiglitazone in neuroprotection after transient cerebral ischemia: activation of dual specificity phosphatase.
4/2012Release of mitochondrial apoptogenic factors and cell death are mediated by CK2 and NADPH oxidase.
12/2011Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke.
4/2011Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection.
3/2011NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia.
7/2010Oxidative stress increases phosphorylation of IkappaB kinase-alpha by enhancing NF-kappaB-inducing kinase after transient focal cerebral ischemia.
1/2010Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia.
11/2009CK2 is a novel negative regulator of NADPH oxidase and a neuroprotectant in mice after cerebral ischemia.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Pak H Chan Research Topics

Disease

56Brain Ischemia (Cerebral Ischemia)
01/2015 - 01/2002
28Ischemia
01/2014 - 01/2002
22Stroke (Strokes)
01/2014 - 01/2002
15Brain Injuries (Brain Injury)
05/2012 - 03/2002
14Reperfusion Injury
01/2015 - 03/2002
10Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2012 - 04/2002
9Anoxia (Hypoxia)
01/2014 - 10/2002
4Infarction
01/2014 - 04/2002
4Inflammation
06/2011 - 06/2006
4Brain Edema (Cerebral Edema)
12/2010 - 04/2002
4Edema
10/2008 - 09/2003
3Cerebral Hemorrhage
03/2014 - 09/2008
3Hypoglycemia (Reactive Hypoglycemia)
10/2008 - 06/2003
3Spinal Cord Injuries (Spinal Cord Injury)
01/2008 - 12/2002
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2006 - 08/2002
3Hypothermia
10/2002 - 01/2002
2Thrombosis (Thrombus)
01/2014 - 01/2013
2Transient Ischemic Attack
01/2013 - 05/2003
2Brain Infarction
06/2011 - 07/2009
2Heart Arrest (Cardiac Arrest)
07/2009 - 10/2008
2Central Nervous System Diseases (CNS Diseases)
10/2008 - 08/2002
2Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
05/2007 - 08/2006
2Hyperglycemia
03/2007 - 05/2002
1Hypotension (Low Blood Pressure)
01/2015
1Neurologic Manifestations (Neurological Manifestations)
03/2014
1Nervous System Diseases (Neurological Disorders)
11/2012

Drug/Important Bio-Agent (IBA)

39Superoxide DismutaseIBA
02/2013 - 01/2002
24ZincIBA
02/2013 - 01/2002
22CopperIBA
02/2013 - 01/2002
20Reactive Oxygen Species (Oxygen Radicals)IBA
09/2012 - 12/2002
16Superoxides (Superoxide)IBA
09/2012 - 01/2002
10Cytochromes c (Cytochrome c)IBA
04/2012 - 01/2002
7NADPH Oxidase (NAD(P)H oxidase)IBA
04/2012 - 04/2007
7Proteins (Proteins, Gene)IBA
08/2006 - 10/2003
6OxygenIBA
01/2015 - 01/2002
6Phosphotransferases (Kinase)IBA
06/2005 - 09/2002
5Glucose (Dextrose)FDA LinkGeneric
01/2015 - 04/2005
5Protein Kinases (Protein Kinase)IBA
09/2012 - 01/2003
5Messenger RNA (mRNA)IBA
05/2012 - 08/2002
5NF-kappa B (NF-kB)IBA
12/2008 - 06/2005
4DNA (Deoxyribonucleic Acid)IBA
02/2013 - 10/2003
4Proline (L-Proline)FDA Link
01/2008 - 02/2004
4Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2007 - 05/2002
4eIF-2 Kinase (eIF 2 Kinase)IBA
06/2005 - 08/2003
4LipidsIBA
01/2005 - 10/2003
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2012 - 05/2009
3AnionsIBA
09/2012 - 10/2008
34- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
06/2011 - 07/2009
3Free RadicalsIBA
04/2011 - 01/2002
3Matrix MetalloproteinasesIBA
09/2008 - 05/2004
3glycogen synthase kinase 3 betaIBA
05/2007 - 08/2006
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
12/2006 - 11/2004
3Peptide Initiation Factors (Initiation Factor)IBA
06/2005 - 08/2003
3Adenosine Triphosphate (ATP)IBA
04/2004 - 10/2002
3Caspase 9IBA
09/2003 - 01/2002
3Caspase 3 (Caspase-3)IBA
06/2003 - 01/2002
2Tissue Plasminogen Activator (Alteplase)FDA Link
01/2014 - 09/2008
2Inhibitor of Apoptosis ProteinsIBA
11/2013 - 06/2004
2AntioxidantsIBA
02/2013 - 10/2003
2Interleukin-6 (Interleukin 6)IBA
11/2012 - 12/2011
2Mitogen-Activated Protein KinasesIBA
09/2012 - 03/2003
2CalciumIBA
05/2012 - 06/2003
28-hydroxy-2'-deoxyguanosineIBA
04/2012 - 07/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2011 - 10/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2011 - 05/2002
2EnzymesIBA
04/2011 - 01/2005
2Oxidants (Oxidizing Agents)IBA
04/2011 - 10/2003
2I-kappa B KinaseIBA
07/2010 - 10/2005
2acetovanillone (apocynin)IBA
07/2009 - 04/2007
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2009 - 05/2002
2p38 Mitogen-Activated Protein KinasesIBA
10/2008 - 03/2003
2Insulin (Novolin)FDA Link
04/2007 - 06/2003
2CytokinesIBA
04/2007 - 10/2005
2hydroethidineIBA
03/2007 - 03/2002
2Proteasome Endopeptidase Complex (Proteasome)IBA
05/2006 - 02/2005
2ErythropoietinFDA Link
03/2006 - 06/2005
2Apoptosis Inducing FactorIBA
12/2005 - 06/2003
2Complementary DNA (cDNA)IBA
10/2005 - 02/2003
2Nerve Growth Factor (NGF)IBA
07/2005 - 02/2004
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
06/2005 - 05/2003
2Nucleic AcidsIBA
01/2005 - 01/2004
2N-Methylaspartate (NMDA)IBA
07/2003 - 03/2003
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2003 - 11/2002
2KetamineFDA LinkGeneric
11/2002 - 04/2002
2Niacinamide (Nicotinamide)FDA LinkGeneric
11/2002 - 04/2002
1glucuronyl glucosamine glycan sulfate (Vessel)IBA
01/2015
1phenylmethylpyrazoloneIBA
01/2014
1Complement System Proteins (Complement)IBA
02/2013
1Complement C3 (C3 Complement)IBA
02/2013
1rosiglitazone (Avandia)FDA Link
01/2013
1Dual-Specificity PhosphatasesIBA
01/2013
1InterleukinsIBA
11/2012
1ThioredoxinsIBA
05/2012
1tetrabromocinnamic acidIBA
04/2012

Therapy/Procedure

4Transplantation (Transplant Recipients)
03/2014 - 03/2012
2Cell Transplantation
11/2012 - 09/2012
2Sutures (Suture)
06/2003 - 03/2002
1Ligation
01/2014
1Thrombolytic Therapy
01/2014
1Stents
01/2013